Brohl Andrew S, Patidar Rajesh, Turner Clesson E, Wen Xinyu, Song Young K, Wei Jun S, Calzone Kathleen A, Khan Javed
Sarcoma Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.
Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Genet Med. 2017 Aug;19(8):955-958. doi: 10.1038/gim.2016.206. Epub 2017 Jan 26.
Ewing sarcoma is a small round blue cell tumor that is highly malignant and predominantly affects the adolescent and young adult population. It has long been suspected that a genetic predisposition exists for this cancer, but the germ-line genetic underpinnings of this disease have not been well established.
We performed germline variant analysis of whole-genome or whole-exome sequencing of samples from 175 patients affected by Ewing sarcoma.
We discovered pathogenic or likely pathogenic germline mutations in 13.1% of our cohort. Pathogenic mutations were highly enriched for genes involved with DNA damage repair and for genes associated with cancer predisposition syndromes.
Our findings reported here have important clinical implications for patients and families affected by Ewing sarcoma. Genetic counseling should be considered for patients and families affected by this disease to take advantage of existing risk management strategies. Our study also highlights the importance of germline sequencing for patients enrolled in precision-medicine protocols.Genet Med advance online publication 26 January 2017.
尤因肉瘤是一种小圆蓝细胞瘤,恶性程度高,主要影响青少年和青年人群。长期以来人们一直怀疑这种癌症存在遗传易感性,但该疾病的种系遗传基础尚未完全明确。
我们对175例尤因肉瘤患者的样本进行了全基因组或全外显子组测序的种系变异分析。
我们在13.1%的队列中发现了致病性或可能致病性的种系突变。致病性突变在参与DNA损伤修复的基因以及与癌症易感综合征相关的基因中高度富集。
我们在此报告的研究结果对受尤因肉瘤影响的患者和家庭具有重要的临床意义。对于受该疾病影响的患者和家庭,应考虑进行遗传咨询,以利用现有的风险管理策略。我们的研究还强调了种系测序对于参与精准医疗方案的患者的重要性。《遗传医学》2017年1月26日在线优先发表。